390 related articles for article (PubMed ID: 30454850)
1. Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State.
Maki KC; Palacios OM; Buggia MA; Trivedi R; Dicklin MR; Maki CE
Clin Ther; 2018 Dec; 40(12):2065-2076. PubMed ID: 30454850
[TBL] [Abstract][Full Text] [Related]
2. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate.
Qin Y; Nyheim H; Haram EM; Moritz JM; Hustvedt SO
Lipids Health Dis; 2017 Oct; 16(1):204. PubMed ID: 29037249
[TBL] [Abstract][Full Text] [Related]
3. A Novel Self-Micro-Emulsifying Delivery System Enhances Enrichment of Eicosapentaenoic Acid and Docosahexaenoic Acid after Single and Repeated Dosing in Healthy Adults in a Randomized Trial.
West AL; Kindberg GM; Hustvedt SO; Calder PC
J Nutr; 2018 Nov; 148(11):1704-1715. PubMed ID: 30203029
[TBL] [Abstract][Full Text] [Related]
4. Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid Technologies
Lopez-Toledano MA; Thorsteinsson T; Daak AA; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
J Clin Lipidol; 2017; 11(2):394-405. PubMed ID: 28502496
[TBL] [Abstract][Full Text] [Related]
5. A self-emulsifying Omega-3 ethyl ester formulation (AquaCelle) significantly improves eicosapentaenoic and docosahexaenoic acid bioavailability in healthy adults.
Bremmell KE; Briskey D; Meola TR; Mallard A; Prestidge CA; Rao A
Eur J Nutr; 2020 Sep; 59(6):2729-2737. PubMed ID: 31637467
[TBL] [Abstract][Full Text] [Related]
6. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies
Lopez-Toledano MA; Thorsteinsson T; Daak A; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
Clin Ther; 2017 Mar; 39(3):581-591. PubMed ID: 28189364
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
Dunbar RL; Gaudet D; Davidson M; Rensfeldt M; Yang H; Nilsson C; Kvarnström M; Oscarsson J
Lipids Health Dis; 2020 May; 19(1):117. PubMed ID: 32473640
[TBL] [Abstract][Full Text] [Related]
8. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study.
Davidson MH; Johnson J; Rooney MW; Kyle ML; Kling DF
J Clin Lipidol; 2012; 6(6):573-84. PubMed ID: 23312053
[TBL] [Abstract][Full Text] [Related]
9. A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
Lapointe JF; Harvey L; Aziz S; Jordan H; Hegele RA; Lemieux P
Clin Ther; 2019 Mar; 41(3):426-444. PubMed ID: 30799231
[TBL] [Abstract][Full Text] [Related]
10. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
Offman E; Marenco T; Ferber S; Johnson J; Kling D; Curcio D; Davidson M
Vasc Health Risk Manag; 2013; 9():563-73. PubMed ID: 24124374
[TBL] [Abstract][Full Text] [Related]
11. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
12. Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial.
Shimada H; Nilsson C; Noda Y; Kim H; Lundström T; Yajima T
J Atheroscler Thromb; 2017 Sep; 24(9):980-987. PubMed ID: 28344197
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial comparing omega-3 fatty acid plasma levels after ingestion of emulsified and non-emulsified cod liver oil formulations.
Conus N; Burgher-Kennedy N; van den Berg F; Kaur Datta G
Curr Med Res Opin; 2019 Apr; 35(4):587-593. PubMed ID: 30106311
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil.
Schuchardt JP; Schneider I; Meyer H; Neubronner J; von Schacky C; Hahn A
Lipids Health Dis; 2011 Aug; 10():145. PubMed ID: 21854650
[TBL] [Abstract][Full Text] [Related]
15. In vitro dissolution behaviour and absorption in humans of a novel mixed l-lysine salt formulation of EPA and DHA.
Manusama K; Balvers M; Diepeveen-de Bruin M; Headley L; Bosi R; Schwarm M; Witkamp R
Prostaglandins Leukot Essent Fatty Acids; 2021 Jan; 164():102232. PubMed ID: 33360684
[TBL] [Abstract][Full Text] [Related]
16. Wax Ester Rich Oil From The Marine Crustacean, Calanus finmarchicus, is a Bioavailable Source of EPA and DHA for Human Consumption.
Cook CM; Larsen TS; Derrig LD; Kelly KM; Tande KS
Lipids; 2016 Oct; 51(10):1137-1144. PubMed ID: 27604086
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.
Galli C; Maggi FM; Risé P; Sirtori CR
Br J Clin Pharmacol; 2012 Jul; 74(1):60-5. PubMed ID: 22242645
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers.
Rusca A; Di Stefano AF; Doig MV; Scarsi C; Perucca E
Eur J Clin Pharmacol; 2009 May; 65(5):503-10. PubMed ID: 19148629
[TBL] [Abstract][Full Text] [Related]
20. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
Offman E; Davidson M; Abu-Rashid M; Chai P; Nilsson C
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):815-825. PubMed ID: 28116646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
